ALGS
Price
$4.68
Change
+$0.11 (+2.41%)
Updated
Apr 17 closing price
Capitalization
28.61M
CLLS
Price
$1.45
Change
+$0.02 (+1.40%)
Updated
Apr 17 closing price
Capitalization
195.28M
17 days until earnings call
Ad is loading...

ALGS vs CLLS

Header iconALGS vs CLLS Comparison
Open Charts ALGS vs CLLSBanner chart's image
Aligos Therapeutics
Price$4.68
Change+$0.11 (+2.41%)
Volume$79.75K
Capitalization28.61M
Cellectis SA
Price$1.45
Change+$0.02 (+1.40%)
Volume$36.08K
Capitalization195.28M
ALGS vs CLLS Comparison Chart
Loading...
ALGS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CLLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALGS vs. CLLS commentary
Apr 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALGS is a Hold and CLLS is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 20, 2025
Stock price -- (ALGS: $4.68 vs. CLLS: $1.45)
Brand notoriety: ALGS and CLLS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALGS: 40% vs. CLLS: 8%
Market capitalization -- ALGS: $28.61M vs. CLLS: $195.28M
ALGS [@Biotechnology] is valued at $28.61M. CLLS’s [@Biotechnology] market capitalization is $195.28M. The market cap for tickers in the [@Biotechnology] industry ranges from $282.79B to $0. The average market capitalization across the [@Biotechnology] industry is $2.07B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALGS’s FA Score shows that 1 FA rating(s) are green whileCLLS’s FA Score has 1 green FA rating(s).

  • ALGS’s FA Score: 1 green, 4 red.
  • CLLS’s FA Score: 1 green, 4 red.
According to our system of comparison, CLLS is a better buy in the long-term than ALGS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALGS’s TA Score shows that 5 TA indicator(s) are bullish while CLLS’s TA Score has 4 bullish TA indicator(s).

  • ALGS’s TA Score: 5 bullish, 4 bearish.
  • CLLS’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ALGS is a better buy in the short-term than CLLS.

Price Growth

ALGS (@Biotechnology) experienced а +17.29% price change this week, while CLLS (@Biotechnology) price change was +17.89% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.03%. For the same industry, the average monthly price growth was -13.25%, and the average quarterly price growth was -24.49%.

Reported Earning Dates

ALGS is expected to report earnings on Nov 06, 2024.

CLLS is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+7.03% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CLLS($195M) has a higher market cap than ALGS($28.6M). CLLS YTD gains are higher at: -19.444 vs. ALGS (-88.253). CLLS has higher annual earnings (EBITDA): -9.46M vs. ALGS (-86.53M). CLLS has more cash in the bank: 260M vs. ALGS (56.9M). ALGS has less debt than CLLS: ALGS (8.38M) vs CLLS (91.5M). CLLS has higher revenues than ALGS: CLLS (41.5M) vs ALGS (3.95M).
ALGSCLLSALGS / CLLS
Capitalization28.6M195M15%
EBITDA-86.53M-9.46M915%
Gain YTD-88.253-19.444454%
P/E RatioN/AN/A-
Revenue3.95M41.5M10%
Total Cash56.9M260M22%
Total Debt8.38M91.5M9%
FUNDAMENTALS RATINGS
CLLS: Fundamental Ratings
CLLS
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
25
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
56
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALGSCLLS
RSI
ODDS (%)
Bullish Trend 4 days ago
77%
Bearish Trend 4 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
71%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
78%
MACD
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 4 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
76%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
69%
Advances
ODDS (%)
Bullish Trend 6 days ago
80%
Bullish Trend 7 days ago
78%
Declines
ODDS (%)
Bearish Trend 13 days ago
90%
Bearish Trend 5 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
85%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
89%
View a ticker or compare two or three
Ad is loading...
ALGS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CLLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME26.780.53
+2.02%
GameStop Corp
AAPL196.982.71
+1.39%
Apple
BTC.X85063.414000612.609400
+0.73%
Bitcoin cryptocurrency
SPY525.66N/A
N/A
SPDR® S&P 500® ETF
TSLA241.37-0.18
-0.07%
Tesla

ALGS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALGS has been loosely correlated with XNCR. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if ALGS jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALGS
1D Price
Change %
ALGS100%
+2.41%
XNCR - ALGS
39%
Loosely correlated
+1.89%
RLAY - ALGS
33%
Loosely correlated
+3.07%
CRNX - ALGS
31%
Poorly correlated
+2.84%
TVTX - ALGS
30%
Poorly correlated
+2.40%
CLLS - ALGS
30%
Poorly correlated
+1.40%
More

CLLS and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLLS has been loosely correlated with SLN. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if CLLS jumps, then SLN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLLS
1D Price
Change %
CLLS100%
+1.40%
SLN - CLLS
43%
Loosely correlated
+8.28%
PMVP - CLLS
39%
Loosely correlated
+2.00%
TGTX - CLLS
36%
Loosely correlated
+0.29%
CLGN - CLLS
33%
Poorly correlated
N/A
DTIL - CLLS
32%
Poorly correlated
+0.20%
More